Browsing Research and Innovation Unit by Subject "ScN2a cells"

Now showing items 1-2 of 2

The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells

Pagadala, Nataraj S.; Bjorndahl, Trent C.; Joyce, Michael; Wishart, David S.; Syed, Khajamohiddin; Landi, Abdolamir (Bioorganic & Medicinal Chemistry, 2017)

Prion diseases are fatal neurodegenerative disorders of the central nervous system characterized by the accumulation of a protease resistant form (PrPSc) of the cellular prion protein (PrPC) in the brain. Two types of ...
The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells

Pagadala, Nataraj S.; Bjorndahl, Trent C.; Joyce, Michael; Wishart, David S.; Syed, Khajamohiddin; Landi, Abdolamir (Elsevier Ltd: Bioorganic & Medicinal Chemistry, 2017)

Prion diseases are fatal neurodegenerative disorders of the central nervous system characterized by the accumulation of a protease resistant form (PrPSc) of the cellular prion protein (PrPC) in the brain. Two types of ...

Search DSpace